Clozapine and aripiprazole‐induced neutropenia-Reference-Cited by-同舟云学术

Clozapine and aripiprazole‐induced neutropenia

Published:2023-01 Issue:1 Volume:27 Page:9-11
ISSN:1367-7543
Container-title:Progress in Neurology and Psychiatry
language:en
Short-container-title:Prog Neurol Psychiatry

Author:

Tial Stephanie Vel En¹,Dixon Michael¹

Affiliation:

1. Dr Vel En Tial is a Speciality Doctor working in Forensic Psychiatry at Lynebank Hospital Dunfermiline, NHS Fife, and Mr Dixon is Lead Clinical Pharmacist for Medicines Information, Becklin Centre, Leeds and York Partnership NHS Trust, UK.

Abstract

Neutropenia is a well‐known adverse side‐effect of clozapine that can also be seen with other atypical antipsychotics. In this article the authors discuss a patient who experienced neutropenia with clozapine and who subsequently redeveloped neutropenia with aripiprazole after a short trial. The case illustrates that close monitoring and caution is advisable when trialing patients on any further antipsychotics after a neutropenic event with clozapine.

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pnp.774

Reference19 articles.

1. Neutropenia and Agranulocytosis in Patients Receiving Clozapine in the UK and Ireland

2. Differences in antipsychotic‐related adverse events in adult, pediatric, and geriatric populations;Sagreiya H;Cureus,2017

3. MHRA. Interactive Drug Analysis Profile: Aripiprazole (https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000830181335.zip&agency=MHRA; accessed 3 January 2023).

4. Clozaril connect. Clozaril and red alert management (www.hcpinfo.clozaril.co.uk/-/media/clozarilcouk/pdf/uk_factsheets/clz_2020_0069_uk_cpms_factsheet-6_clozaril_and_red_alert_management.pdf; accessed 3 January 2023).

5. Sudden Late Onset of Clozapine-Induced Agranulocytosis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2023-03-04